Shelterin proteins and cancer

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 8, 2015, Pages 3085-3090

  Patel, Trupti N V ^a   Vasan, Richa ^a   Gupta, Divanshu ^a   Patel, Jay ^a   Trivedi, Manjari ^a  

^a VIT UNIVERSITY   (India)

Author keywords

Shelterin proteins; Telomerase; Telomeres; Tumorigenesis

Indexed keywords

SHELTERIN, HUMAN; TELOMERE BINDING PROTEIN; TELOMERIC REPEAT BINDING FACTOR 2; TRF2 PROTEIN, MOUSE;

ANIMAL; DNA DAMAGE; GENETICS; HUMAN; METABOLISM; NEOPLASM; PATHOLOGY; TELOMERE;

ANIMALS; DNA DAMAGE; HUMANS; NEOPLASMS; TELOMERE; TELOMERE-BINDING PROTEINS; TELOMERIC REPEAT BINDING PROTEIN 2;

EID: 84929012670     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.8.3085     Document Type: Short Survey

References (64)

1. Alessandro B, Susan S, Laura C, Peter E, Titia de L (1997). TRF1 is a dimer and bends telomeric DNA. EMBO J, 16, 1785-94.
2. Bas VS, Titia de L (1997). Control of telomere length by the human telomeric protein TRF1. Nature, 385, 740-3.
3. Bas VS, Agata S, Titia de L (1998). TRF2 protects human telomeres from end to end fusions. J cell, 32, 401-13.
4. Baumann P, Cech TR (2001). Pot1, the putative telomere end-binding protein in fission yeast and humans. Science, 292, 1171-5.
5. Baumann P, Podell E, Cech TR (2002). Human Pot1 (protection of telomeres) protein: cytolocalization, gene structure, and alternative splicing. Mol Cell Biol, 22, 8079-87.
6. Chen LY, Liu D, Songyang Z (2007). Telomere maintenance through spatial control of telomeric proteins. Mol Cell Biol, 27, 5898-909.
7. Davoli T, Denchi EL, de Lange T (2010). Persistent telomere damage induces bypass of mitosis and tetraploidy. Cell, 141, 81-93.
8. Denchi EL and de Lange T (2007). Protection of telomeres through independent control of ATM and ATR by TRF2 and POT1. Nature, 448, 1068-71.
9. Fei L, Xiao-Yun P, Shao-Guang H, et al (2012). Expression of hPOT1 in HeLa cells and probability of gene variation of hpot1Exon14 on endometrial cancer are much higher than in other cancers. Asian Pac J Cancer Prev, 13, 5659-63.
10. Feng W, Elaine RP, Arthur JZ, et al (2007). The POT1-TPP1 telomere complex is a telomerase processivity factor. Nature, 445, 506-10.
11. Franklin LZ, Luis FZB, Adam F, et al (2012). TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends. Cell, 150, 481-94.
12. He H, Multani AS, Cosme-Blanco W, et al (2006). POT1b protects telomeres from end-to-end chromosomal fusions and aberrant homologous recombination. EMBO J, 25, 5180-90.
13. He H, Wang Y, Guo X, et al (2009). Pot1b deletion and telomerase haploinsufficiency in mice initiate an ATR-dependent DNA damage response and elicit phenotypes resembling dyskeratosiscongenita. Mol Cell Biol, 29, 229-40.
14. Hockemeyer D, Daniels JP, Takai H, de Lange T (2006). Recent expansion of the telomeric complex in rodents: Two distinct POT1 proteins protect mouse telomeres. Cell, 126, 63-77.
15. Hockemeyer D, Sfeir AJ, Shay JW, Wright WE, de Lange T (2005). POT1 protects telomeres from a transient DNA damage response and determines how human chromosomes end. EMBO J, 24, 2667-8.
16. Hua H, Yang Z, Mei Z, Shuai Y, Xiao-Qiu L (2010). Expression of TRF, TRF2, TIN2, TERT, Ku70, and BRCA1proteins associated with telomere shortening and may contribute to multistage carcinogenesis of gastric cancer. J Cancer Res Clin Oncol, 136, 1407-14.
17. Huawei X, Dan L, Zhou S (2008). The telosome/shelterin complex and its functions. Genome Biology, 9, 232.
18. Huichen W, AngeRonel P, Yoshihiko T, et al (2003). Biochemical evidence for Ku-independent backup pathways of NHEJ. Nucleic Acids Research, 31, 5378-88.
19. Jason AS, Mary FC, Feng W, Carolyn MP (2012). Maintaining the end: Roles of telomere proteins in end protection, telomere replication and length regulation. J Mutation research, 730, 12-9.
20. Jeffrey ZSY, Dirk H, Andrew NK, et al (2004). POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev, 18, 1649-54.
21. Jill RD and Titia de L (2007). The role of the poly(ADP-ribose) polymerase tankyrase1 in telomere length control by the TRF1 component of the shelterin complex. J Biol Chem, 282, 22662-7.
22. Jing Y, Christelle L, Serge B, et al (2010). TRF2 and apollo cooperate with Topoisomerase 2α to protect human telomeres from replicative damage. J Cell, 142, 230-42.
23. John RW, Xu-Dong Z (2012). Post-translational modifications of TRF1 and TRF2 and their roles in telomere maintenance. Mechanisms Ageing Development, 133, 421-33.
24. Jorunn EE and Sigridur KB (2005). Genomic instability and cancer: networks involved in response to DNA damage. Mutation Res, 592, 18-28.
25. Judith C, Sahn-ho K, Chang-su L, Miguel R (2001). Cellular senescence, cancer and aging: the telomere connection. Exp Gerontology, 36, 1619-37.
26. Julieta P, Carmen S, Jorge A, et al (2014). Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression. Blood Cells Molecules Diseases, 52, 134-9.
27. Jun L, Chun-Yan X, Shi-Zhong C, et al (2013). Senescence effects of Angelica sinensis polysaccharides on human acute myelogenous leukaemia stem and progenitor cells. Asian Pac J Cancer Prev, 14, 6549-56.
28. Kaori KT, Tatsuya K, Jill RD, David F, Titia de L (2011). Telomere Protection by TPP1/POT1 Requires Tethering to TIN2. Molecular Cell, 44, 647-59.
29. Karel R, Michelle LH, Dorothy ES (2006). The role of the non homologous end-joining DNA double-strand break repair pathway in telomere biology. Ann Rev Genetics, 40, 237-77.
30. Kelleher C, Kurth I, Lingner J (2005). Human protection of telomeres 1 (POT1) is a negative regulator of telomerase activity in vitro. Mol Cell Biol, 25, 808-18.
31. Kentaro H, Toshio S, Fumio A (2013). Shelterin component protection of telomeres 1 (Pot1) plays a critical role in the self-renewal of HSCs. Exp Hematology, 41, 37.
32. Kim SH, Beausejour C, Davalos AR, et al (2004). TIN2 mediates functions of TRF2 at human telomeres. J Biol Chem, 279, 43799-804.
33. Lei M, Podell ER, Cech TR (2004). Structure of human POT1 bound to telomeric single-stranded DNA provides a model for chromosome end-protection. Nat Struct Mol Biol, 11, 1223-9.
34. Lingjun M, Joseph KH, Qubo Z, Tao L, Robert YLT (2011). Nucleostemin inhibits TRF1 dimerization and shortens its dynamic association with the telomere. J Cell Science, 124, 3706-14.
35. Liu D, Safari A, O'Connor MS, et al (2004). PTOP interacts with POT1 and regulates its localization to telomeres. Nat Cell Biol, 6, 673-80.
36. Liu H, Qin-Qin W, Wen-Bo W, et al (2013). Suppression of Ku80 correlates with Radio-sensitivity and Telomere Shortening in the U2OS telomere-negative osteosarcoma cell line. Asian Pac J Cancer Prev, 14, 795-99.
37. Liuh-Yow C, Dan L, Zhou S (2007). Telomere maintenance through spatial control of telomeric proteins. Mol Cell Biol, 27, 5898.
38. Liuh-Yow C, Yi Z, Qinfen Z, et al (2012). Mitochondrial localization of telomeric protein TIN2 links telomere regulation to metabolic control. Molecular Cell, 47, 839-50.
39. Louise F, Lynda C, Heidi M, Titia de L, Daniela R (2001). Structure of the TRFH dimerization domain of the human telomeric proteins TRF1 and TRF2. Molecular Cell, 8, 351-61.
40. Masafumi N, Xiao ZZ, Shuji K, Kun PL (2002). Involvement of the telomeric protein Pin2/TRF1 in the regulation of the mitotic spindle. FEBS Letters, 514, 193-8.
41. Michael G, Charles L (2013). A comprehensive model for the recognition of human telomeres by TRF1. J Mol Biol, 425, 2910-21.
42. Moretti P, Freeman K, Coodly L (1994). Evidence that a complex of SIR proteins interacts with the silencer and telomere binding protein RAP1. Genes Dev, 8, 2257-69.
43. Munoz P, Raquel B, Maria AB (2006). Perspective Role of the TRF2 telomeric protein in cancer and ageing. J Cell Cycle, 5, 718-21.
44. O'Connor MS, Amin S, Huawei X, Dan L, Zhou S (2006). A critical role for TPP1 and TIN2 interaction in high-order telomeric complex assembly. Proc Natl Acad Sci USA, 103, 11874-9.
45. Paula M and Maria AB (2010). Role of shelterin in cancer and aging. J Aging Cell, 9, 653-66.
46. Qian C and Jiandong C (2010). Mechanism of p53 stabilization by ATM after DNA damage. Cell Cycle, 9, 472-8.
47. Qingqing H, Ping Z, Jia-Heng T, et al (2014). G-quadruplex-mediated regulation of telomere binding protein POT1 gene expression. Biochim Biophys Acta, 1840, 2222-33.
48. Raffaella D, Diego L (2011). Shelterin complex and associated factors at human telomeres Landes Bioscience. Nucleus, 2, 119-35.
49. Rekha R, Hong Z, Hua H, et al (2010). The function of classical and alternative non homologous end-joining pathways in the fusion of dysfunctional telomeres. The EMBO J, 29, 2598-610.
50. Savage SA, Giri N, Baerlocher GM, et al (2008). TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosiscongenita. Am J Hum Genet, 82, 501-9.
51. Shuji K, Xiao ZZ, Yael Z, et al (2001). Telomeric protein Pin2/TRF1 as an important ATM target in response to double strand DNA breaks. J Biological Chemistry, 276, 29282-1.
52. Sullivan LB, Santos JH, Chandel NS (2012). Mitochondria and telomeres: the promiscuous roles of TIN2. Molecular Cell, 47, 823-4.
53. Tatsuya K, Gail AO, Catherine EK, Titia de L (2010). Telomere Protection by TPP1 Is Mediated by POT1a and POT1b. Mol Cell Biol, 30, 1059-66.
54. Greider CW (1999). Telomeres do d-loop-t-loop. Cell, 97, 419-22.
55. Titia de L (2005). Shelterin: The protein complex that shapes and safeguards human telomeres. Genes Dev, 19, 2100-10.
56. Veldman T, Etheridge KT, Counter CM (2004). Loss of hPot1 function leads to telomere instability and a cut-like phenotype. Curr Biol, 14, 2264-70.
57. Xiao N, Chen S, Ma Y, et al (2012). Interaction of Berberine derivative with protein POT1 affects telomere function in cancer cells. BBRC, 419, 567-72.
58. Xiao ZZ, Kilian P, Kun PL (2003). Role of Pin2/TRF1 in telomere maintenance and cell cycle control. J cellular biochemistry, 89, 19-37.
59. Xiaolan G, Yibin D, Yahong L, et al (2007). Dysfunctional telomeres activate an ATM-ATR-dependent DNA damage response to suppress tumorigenesis. The EMBO Journal, 26, 4709-19.
60. Xiaoping T, Bo C, Xiaochuan L (2009). Telomere and telomerase as targets for cancer therapy. Appl Biochem Biotechnol, 160, 1460-72.
61. Xin H, Dan L, Yi Z, et al (2013). AKT regulates TPP1 homodimerization and telomere protection. Aging Cell, 12, 1091-9.
62. Ye JZ, Donigian JR, van Overbeek M, et al (2004). TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres. J Biol Chem, 279, 47264-71.
63. Yi Z, Liuh-Yow C, Xin H, et al (2012). Phosphorylation of TPP1 regulates cell cycle-dependent telomerase recruitment. Proc Natl Acad Sci USA, 110, 5457-62.
64. Yoon RH and In KC (2009). Ubiquitin ligase RLIM modulates telomere length homeostasis through a proteolysis of TRF1. J Biol Chem, 284, 8557-66.